ForFarmers has announced that Cees de Jong will be nominated as a member of its Supervisory Board. The nomination will be submitted to the Annual General Meeting of shareholders on April 26, when Henk Mulder will retire.
De Jong is currently President and CEO of the globally operating Danish stock listed bioscience company Chr. Hansen, developer of sustainable solutions for the food, nutritional, pharmaceutical and agricultural industries.
Before he was appointed to CEO of Chr. Hansen in 2013, de Jong held various management and board positions in the biopharmaceutical and food industries. His professional career started in 1989 after he had obtained his MBA and a Medical Doctorate degree from Erasmus University in Rotterdam.
His career started at Gist-Brocades (the Netherlands), and when the company was acquired by DSM in 1998, de Jong stayed on. He was appointed to President of the Business Group Anti-Infectives. In 2000, he moved to Campina to manage the Industrial Products division. From 2003 to 2007, de Jong worked for Quest International as President of the Flavor division and member of the board. Subsequently, he became Chief Operating Officer and board member of the biotech company Crucell, which was taken over by Johnson & Johnson in 2011.
Jan Eggink, chairman of the Supervisory Board of ForFarmers, says, “Given Cees de Jong's broad international experience in large branch-related organizations, we are extremely pleased to nominate him as a member of our Supervisory Board. We believe he will strengthen the ForFarmers Board.”